ACAD FY 2015 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$61,000-49.2% YoY

Gross Profit

-$76M-125095.1% margin

Operating Income

-$165M-269855.7% margin

Net Income

-$164M-269578.7% margin

EPS (Diluted)

$-1.63

Cash Flow

Operating Cash Flow

-$122M

Free Cash Flow

-$124M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$222M

Total Liabilities

$22M

Stockholders' Equity

$200M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$61,000	$120,000	-49.2%
Gross Profit	-$76M	-$60M	-26.2%
Operating Income	-$165M	-$93M	-76.6%
Net Income	-$164M	-$92M	-77.8%